Search
for

    Sort by

    Research 571–600 of 1000+

    1. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    2. Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2013 · 34 citations
    3. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations
    4. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    5. Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq Baghdad Science Journal · 2020 · 2 citations
    6. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    7. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. PubMed · 2026
    8. 5-alpha reductase inhibitors use in prostatic disease and beyond Translational Andrology and Urology · 2023
    9. Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia Global Journal of Reproductive Medicine · 2023
    10. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    11. Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment Journal of Urology and Nephrology Open Access · 2016
    12. UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume Urology · 2011
    13. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    14. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    15. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study British Journal of Cancer · 2017 · 65 citations
    16. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use Scandinavian journal of urology · 2016 · 29 citations
    17. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase BJU international · 2009 · 29 citations
    18. Sculpting the future: A narrative review of 3D printing in plastic surgery and prosthetic devices Health Science Reports · 2024 · 22 citations
    19. Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer Journal of the American Heart Association · 2021 · 8 citations
    20. Androgen receptor-mediated gene activation in prostate cancer cells UEF eRepo (University of Eastern Finland) · 2010 · 1 citations
    21. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    22. 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES The Journal of Urology · 2012
    23. Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer InTech eBooks · 2011
    24. S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY European Urology Supplements · 2010
    25. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    26. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    27. 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia International Journal of Cancer · 2006 · 57 citations
    28. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Therapeutics and Clinical Risk Management · 2009 · 33 citations
    29. Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior Journal of Ethnopharmacology · 2014 · 19 citations
    30. Inhibitory Effects of Serenoa repens on the Kinetic of Pig Prostatic Microsomal 5α-Reductase Activity Endocrine journal · 1998 · 12 citations